Market Profile: High Content Screening

High content screening (HCS) is a high-throughput method, which enables the functional analysis of cells. HCS plays a vital role for drug discovery applications, including drug targets verification and pathway detection, in both the pharmaceutical and biotechnology industries. The technology is often used in neuroscience research, especially in drug development for Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases.

Click here for the full article in The Column